CLINICAL_TRIALS
trial_result
· 2020-08-31
Clinical Trial Update: A Study of CK-2127107 in Patients With Spinal Muscular Atrophy [Phase 2]
Summary
A Phase 2 clinical trial of CK-2127107 in patients with spinal muscular atrophy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cytokinetics | Conditions: Spinal Muscular Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2020-08-31